Status:
COMPLETED
Intranasal Ketamine Effectiveness in Reducing Intramuscular Injection Pain Before Sedation Among Children
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Pain
Intranasal Ketamine
Eligibility:
All Genders
12-7 years
Phase:
PHASE4
Brief Summary
Hypothesis: Intranasal administration of ketamine would reduce the intramuscular pain of ketamine injection in children who undergo procedural sedation and analgesia in the emergency department.
Detailed Description
Ketamine is a well-known medication in children's procedural sedation and analgesia. While it provides good analgesia along with sedation, its injection is painful and causes distress in children. Int...
Eligibility Criteria
Inclusion
- • Children who need to undergo procedural sedation and analgesia
Exclusion
- Weight over 33 Kg
- No Consent from parents/patient
- Needs immediate procedure due to patient's condition
- Growth/mental retardation
- Sensory deficit at the site of intramuscular injection
Key Trial Info
Start Date :
December 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06139380
Start Date
December 2 2023
End Date
May 31 2024
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IKHC
Tehran, Iran